ClinicalTrials.gov
ClinicalTrials.gov Menu

Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00611689
Recruitment Status : Completed
First Posted : February 11, 2008
Last Update Posted : February 4, 2013
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
SCRI Development Innovations, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2008
  Actual Study Completion Date : April 2011